Cancer Clinical Trial Sponsors Increasingly Favor Non-U.S. Sites, FDA Finds
Executive Summary
The number of clinical trials used for registration of anticancer agents performed at least partially outside the U.S. has increased by approximately 50% in the last five years, FDA reported at the American Society of Clinical Oncology annual meeting